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Key points 33 
● Whole-body hyperthermia impairs cardiovascular function and aerobic 34 
exercise capacity, but the contribution of skin hyperthermia to the 35 
ensuing regional cardiovascular strain is unclear.  36 
● Body temperature was manipulated with a water-perfused suit to 37 
examine how hyperthermia affects brain and active limb circulations and 38 
accelerates fatigue during incremental maximal exercise in humans.  39 
● Whole-body hyperthermia, but not skin hyperthermia, accelerated the 40 
reductions in brain and active limb perfusion, compromised aerobic 41 
metabolism and impaired exercise capacity. 42 
● The attenuation in brain and active limb perfusion was associated with 43 
increases in sympathetic vasoconstrictor activity, blunted rise in plasma 44 
ATP and a fall in the arterial partial pressure of CO2. 45 
● These findings challenge the prevailing notion that skin hyperthermia and 46 
hyperperfusion per se is the dominant factor in the development of 47 
cardiovascular strain and fatigue during exercise in hot environments.   48 
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Abstract 65 
Cardiovascular strain and hyperthermia are thought to be important factors 66 
limiting exercise capacity in heat-stressed humans; however, the contribution of 67 
elevations in skin (Tsk) vs. whole body temperatures on exercise capacity has 68 
not been characterised. To ascertain their relationships with exercise capacity, 69 
blood temperature (TB), oxygen uptake (V̇O2), brain perfusion (MCA Vmean), 70 
locomotor limb haemodynamics, and haematological parameters were 71 
assessed during incremental cycling exercise with elevated skin (mild 72 
hyperthermia; HYPmild), combined core and skin temperatures (moderate 73 
hyperthermia; HYPmod), and under control conditions. Both hyperthermic 74 
conditions increased Tsk vs. control (6.2 ± 0.2 °C; P < 0.001), however, only 75 
HYPmod increased resting TB, leg blood flow and cardiac output (Q̇), but not 76 
MCA Vmean. Throughout exercise, Tsk remained elevated in both hyperthermic 77 
conditions, whereas only TB was greater in HYPmod. At exhaustion, oxygen 78 
uptake and exercise capacity were reduced in HYPmod in association with lower 79 
leg blood flow, MCA Vmean and MAP, but similar maximal heart rate and TB. The 80 
attenuated brain and leg perfusion with hyperthermia was associated with a 81 
plateau in MCA and two-legged vascular conductance (VC). Mechanistically, 82 
the falling MCA VC was coupled to reductions in PaCO2 whereas the plateau in 83 
leg vascular conductance was related to markedly elevated plasma [NA] and a 84 
plateau in plasma ATP. These findings reveal that whole-body hyperthermia, 85 
but not skin hyperthermia, compromises exercise capacity in heat-stressed 86 
humans through the early attenuation of brain and active muscle blood flow. 87 
 88 
  89 
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Abbreviations. ATPfv femoral venous ATP concentration; a-vO2diff, 90 
arteriovenous oxygen content difference; CaO2, arterial content of oxygen; 91 
HRmax, maximal heart rate; HYPmild, mild hyperthermia; HYPmod, moderate 92 
hyperthermia; MCA Vmean, middle cerebral artery blood velocity; [NA], 93 
noradrenaline; PaCO2, arterial carbon dioxide pressure; Q̇, cardiac output; 94 
rSO2%, regional cerebral oxygen saturation; Ta, ambient temperature; TB, blood 95 
temperature; Ti, internal temperature; Tsk, mean skin temperature; TOes, 96 
oesophageal temperature; V̇O2max, maximal aerobic power; Wmax, maximal work 97 
rate.   98 
5 
 
Introduction 99 
It is well documented that maximal aerobic exercise capacity (V̇O2max) is 100 
reduced in hot environments inducing whole body hyperthermia (Rowell et al., 101 
1966; Pirnay et al., 1970; Rowell, 1974; Galloway & Maughan, 1997; González-102 
Alonso et al., 2008; Sawka et al., 2011). The precise mechanisms underpinning 103 
the impaired exercise capacity in the heat remain debated, but may result from 104 
the interaction of multiple regulatory processes associated with reduced O2 105 
delivery and modified locomotor muscle and brain metabolism, attainment of 106 
high internal and skin temperatures, and altered central nervous system 107 
neurotransmitter activity and feedback/reflex mechanisms (González-Alonso et 108 
al., 2008; Meeusen & Roelands, 2010; Sawka, 2012; Nybo et al., 2014). The 109 
contribution of these factors to early fatigue in the heat appear to be task and 110 
exercise-intensity dependent (Nybo et al., 2014). There is, however, surprisingly 111 
limited information on the cardiovascular adjustments to incremental exercise 112 
with differing extents of skin and whole-body hyperthermia. 113 
 114 
Restrictions in active skeletal muscle perfusion may play an important role in 115 
the reduced aerobic capacity in hyperthermic conditions. Under control 116 
(normothermic) conditions, skeletal muscle O2 delivery is tightly coupled to the 117 
metabolic demand during sub-maximal exercise (Andersen & Saltin, 1985; Delp 118 
& Laughlin, 1998; Saltin et al., 1998; González-Alonso et al., 2002; Delp & 119 
O’Leary, 2004); regulation that is lost at high intensities as, prior to volitional 120 
exhaustion, systemic and active skeletal muscle (in addition to brain and 121 
respiratory muscle) blood flow becomes restricted (González-Alonso & Calbet, 122 
2003; Mortensen et al., 2005, 2008; Vogiatzis et al., 2009; Calbet et al., 2015). 123 
The attenuated limb blood flow per unit of power when approaching maximal 124 
exercise intensities occurs concomitantly with enhanced local vasoconstrictor 125 
activity and reductions in stroke volume (González-Alonso & Calbet, 2003; 126 
Calbet et al., 2007; Mortensen et al., 2008; Stöhr et al., 2011b; Munch et al., 127 
2014). As a consequence, and in contrast to other important regions of the body 128 
such as the brain (Nybo et al., 2002; González-Alonso et al., 2004; Trangmar et 129 
al., 2014), blunted O2 delivery may compromise local aerobic metabolism, as 130 
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maximal skeletal muscle O2 extraction is achieved during exhaustive exercise 131 
(González-Alonso & Calbet, 2003). It remains unknown whether hyperthermia 132 
accelerates cardiovascular strain during incremental exercise with similar non-133 
linear cardiovascular dynamics.   134 
 135 
An early restriction in regional blood flow may underpin the reduced V̇O2max with 136 
body hyperthermia. The magnitude of the decline in V̇O2max is, however, 137 
variable and largely dependent on the extent of the rise in skin and internal 138 
temperature (Pirnay et al., 1970; Arngrímsson et al., 2004; Kenefick et al., 2010; 139 
Nybo et al., 2014). A critical question is which bodily temperature, or 140 
combination of temperatures, is most closely associated with the reduced 141 
aerobic capacity in heat stress conditions. On the one hand, brief exposure to 142 
heat that does not substantially elevate internal temperature is unlikely to cause 143 
a decline in V̇O2max or impair cardiovascular capacity (Arngrímsson et al., 2004). 144 
In contrast, a reduced aerobic exercise performance has been associated with 145 
the attainment of high skin temperatures without significant elevations in internal 146 
(core) temperature (Ely et al., 2009; Kenefick et al., 2010; Lorenzo et al., 2010; 147 
Sawka et al., 2012). The hypothesis that elevations in skin temperature, by 148 
requiring a large proportion of the cardiovascular capacity, is the primary factor 149 
leading to a compromised aerobic performance has generally been 150 
substantiated with the classical observation that cardiac output is reduced 151 
during the high intensity stages of graded exercise in the heat, compared to a 152 
temperate environment, in untrained men (Rowell et al., 1966). High skin 153 
temperature has therefore been proposed to be a critical factor underpinning 154 
reduced aerobic capacity in the heat (Sawka et al., 2012). However, there is 155 
some evidence that Q̇ is higher during the early stages of intense constant-load 156 
exercise with body hyperthermia in trained individuals (González-Alonso & 157 
Calbet, 2003; González-Alonso et al., 2004), suggesting that high skin blood 158 
flow requirements per se do not compromise systemic perfusion. Hence, whilst 159 
it has long been accepted that the extent of the exogenous heat stress is a 160 
critical factor for the decline in maximal aerobic power, the precise circulatory 161 
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alterations with varying levels of body hyperthermia that partition the roles of 162 
skin vs. whole-body temperature have yet to be systematically investigated. 163 
 164 
The aim of the present study was to investigate the effect of heat stress, 165 
inducing two different grades of hyperthermia, on cardiovascular capacity and 166 
brain and active limb blood flow and metabolism during incremental cycling 167 
exercise to volitional exhaustion. Regional haemodynamics and metabolism 168 
during incremental exercise were assessed; 1) after heat exposure sufficient to 169 
elevate internal and skin temperature, 2) after a brief heat exposure sufficient to 170 
elevate skin temperature and 3) in control conditions. We hypothesised that 171 
combined core and skin hyperthermia, but not skin hyperthermia, would 172 
compromise V̇O2max and exercise capacity in close association with early 173 
restrictions in brain and active-limb perfusion. 174 
 175 
Methods 176 
Ethical approval 177 
All procedures in the present study were approved by the Brunel University 178 
London Research Ethics Committee (RE54-12) and conformed to the guidelines 179 
of the World Medical Association (Declaration of Helsinki). All participants 180 
provided their oral and written and informed consent prior to participation. 181 
 182 
Participants 183 
Nine healthy experienced cyclists (mean ± SD; age 26 ± 6 yrs, stature 181 ± 6 184 
cm, mass 76 ± 9 kg and V̇O2max 4.5 ± 0.1 l·min-1) participated in the study. 185 
Participants arrived at the laboratory postprandial with a normal hydration status 186 
and were required to abstain from strenuous exercise and alcohol intake for 24 187 
h and caffeine consumption for 12 h. 188 
  189 
Experimental design 190 
Participants visited the laboratory on 3 occasions, comprising of a preliminary 191 
trial, a hyperthermia trial and a control trial, each separated by one week. The 192 
preliminary trial familiarised participants with the testing methodology, prior to 193 
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performing an incremental exercise test on a cycle ergometer (Lode Excalibur, 194 
Groningen, Netherlands) to establish maximal work rate (Wmax), maximal heart 195 
rate (HRmax) and V̇O2max. The initial work rate was equivalent to 50% of 196 
predicted V̇O2max, for 2.5 min, followed by increments of 10% predicted every 197 
2.5 min until the limit of tolerance. Participants were instructed to maintain a 198 
cadence between 70-90 r.p.m. and the test was terminated when cycling speed 199 
dropped below 60 r.p.m. for more than 3 s, despite strong verbal 200 
encouragement to continue. After a 1 h recovery period, participants were 201 
dressed in a water-perfused suit (covering the arms, legs and torso), and laid in 202 
a supine position whilst hot water (50 °C) was circulated through, by a 203 
temperature controlled water circulator (Julabo F-34, Seelbach, Germany). A 204 
foil blanket, gloves and hat were worn to minimise heat loss to the environment. 205 
After target increases in skin and core temperature (+6 and +1 oC, respectively), 206 
participants repeated the incremental test to establish HYPmod Wmax. 207 
 208 
On the hyperthermia trial, participants completed three incremental cycling 209 
ergometer exercise tests in the upright position with; 1) HYPmod (with moderate 210 
Tc and high Tsk, after 52 + 3 min of heat exposure), 2) HYPmild (with a high Tsk 211 
but normal Tc, after 13 + 1 min of heat exposure) and, 3) control conditions (Ta 212 
18 °C; 36% RH; with fan cooling). On the control trial, the participants 213 
completed three incremental cycling ergometer exercise tests in a thermo-214 
neutral environment (20 °C; ≤ 50% RH; with fan cooling). Each of the 215 
incremental cycling tests consisted of 5 x ~2.5 min stages at 20, 40, 60, 80 and 216 
100% Wmax, and cycling pedal cadence was stable between 70-90 r.p.m. On 217 
both the hyperthermia and control trials, each incremental test was separated 218 
by 1 h of passive recovery while hydration was maintained through the regular 219 
consumption of water.  220 
 221 
On the hyperthermia trial, brain, active limb and systemic haemodynamics and 222 
blood samples from the brachial artery and femoral vein were obtained 223 
simultaneously at rest and in the final minute of each exercise stage. Skin and 224 
femoral venous temperatures and arterial and femoral venous pressures were 225 
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recorded continuously. The same measures were collected in the control trial, 226 
except for the arterio-venous blood sampling, leg blood flow (LBF) and blood 227 
pressure measurements, and with the addition of oesophageal temperature 228 
(TOes). Full depiction of the experimental protocol of the study is presented in 229 
figure 1. 230 
  231 
Brain, active limb and resting systemic haemodynamics 232 
Middle cerebral artery velocity (MCA Vmean) was measured using a 2 MHz 233 
pulsed trans-cranial Doppler ultrasound system (DWL, Sipplingen, Germany). 234 
The right MCA was insonated through the temporal ultrasound window, distal to 235 
the MCA-anterior cerebral artery bifurcation, at a depth of 45-60 mm (Aaslid et 236 
al., 1982). Regional cerebral (frontal lobe) oxygen saturation (rSO2%) was also 237 
assessed using near-infrared spectroscopy (NIRS; INVOS, Somanetics, Troy, 238 
MI, USA). 239 
 240 
During exercise, LBF was determined using the constant-infusion thermodilution 241 
method (Andersen & Saltin, 1985; González-Alonso et al., 2000). Resting blood 242 
flow (n=4) was obtained using duplex Doppler ultrasonography (Vivid 7, 243 
Dimension, GE Healthcare, UK), or calculated from the directly obtained a-244 
vO2diff and estimated leg V̇O2 (n =5) assuming comparable leg V̇O2 values than 245 
those measured in 4 participants in this study and previous reports from this 246 
laboratory using similar heating protocols (Pearson et al., 2011; Chiesa et al., 247 
2015). Q̇ at rest was estimated using the Modelflow method (Wesseling et al., 248 
1993), from the directly obtained intra-arterial pressure wave forms, corrected 249 
for age, height and weight. 250 
 251 
Catheter placement and blood sampling 252 
Participants rested with a slight head-down tilt whilst catheters for blood 253 
sampling, mean arterial pressure (MAP), femoral venous pressure and blood 254 
temperature were inserted after local anaesthesia (1% lidocaine) into the 255 
brachial artery of the non-dominant arm and anterograde into the right common 256 
femoral vein (Logicath Quad lumen, 18 gauge, 2.3 mm; MXA234X16X85, 257 
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Smiths Medical International LTD), the latter using the Seldinger technique. 258 
Catheters were inserted by an experienced clinician under ultrasound guidance 259 
and were regularly flushed with normal saline (0.9% NaCl) to maintain patency. 260 
The time from catheterisation to the commencement of resting measurements 261 
was ~1 h to allow time for the restoration of normal haemodynamics. 262 
  263 
Blood variables 264 
Arterial and femoral venous blood samples were drawn into pre-heparinised 265 
syringes and analysed immediately for blood gas variables (ABL 800 FLEX, 266 
Radiometer, Copenhagen, Denmark) corrected to blood temperature in the 267 
femoral vein. The analyser was calibrated (one and two-point) at regular 268 
intervals in accordance with manufacturer guidelines. Additional arterial blood 269 
samples were collected in 2 ml syringes and transferred to EDTA tubes, 270 
centrifuged and separated. Plasma noradrenaline was subsequently determined 271 
using an enzyme immunoassay kit (DEE6200, Demeditec Diagnostics GmbH, 272 
Kiel, Germany).   273 
 274 
Heart rate, blood pressure and body temperatures 275 
Heart rate was obtained by telemetry (Polar Electro, Kempele, Finland). Arterial 276 
and femoral venous pressure waveforms were recorded using pressure 277 
transducers (Pressure Monitoring Kit, TruWave, Edwards Lifesciences, 278 
Germany) zeroed at the level of the right atrium in the mid-axillary line (arterial) 279 
and at the level of the tip of the catheter (femoral venous). Pressure waveforms 280 
were amplified (BP amp, ADIstruments) and sampled at 1000 Hz using a data 281 
acquisition unit (Powerlab 16/30, ADInstruments, Oxfordshire, UK) for offline 282 
analysis. For measurements of femoral venous blood temperature (TB), a 283 
thermistor (T204a, PhysiTemp, Clifton, New Jersey, USA) was inserted through 284 
the femoral venous catheter and connected to a thermocouple meter (TC-2000, 285 
Sable Systems, NV: USA) and routed through the data acquisition system. In 286 
the control trial, oesophageal temperature (TOes) was measured using a 287 
thermistor (Physitemp, New England, USA), inserted pernasally into the 288 
oesophagus at a depth of ¼ standing height. Increases in core temperature 289 
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during cycling exercise reflect the rise in femoral venous blood temperature, as 290 
TB and TOes have been shown to be within ~0.1 °C (González-Alonso et al., 291 
1999). Mean skin temperature (Tsk) from four sites (standard weightings of 292 
chest, arm, thigh and calf; (Ramanathan, 1964) was obtained using a wireless 293 
monitoring system (iButton®, Maxim Integrated, San José, CA, USA).  294 
  295 
Calculations 296 
In the hyperthermia trials, brain and active limb vascular conductance (VC) 297 
indices were calculated by dividing MCA Vmean and LBF (for two-legged) by 298 
perfusion pressure (MAP). Direct measurements of Q̇ were not possible during 299 
exercise; however, to provide some insight into these responses, Q̇ was 300 
calculated using the Fick principle, by estimation of systemic O2 extraction from 301 
the directly measured limb O2 extractions (assuming a linear relationship 302 
between these variables, reported in similar exercise protocols; Mortensen et 303 
al., 2008; Munch et al., 2014, and accounting for the known reduction in 304 
systemic O2 extraction with core hypethermia; González-Alonso et al., 2004). 305 
The following equations were used: Y = 1.43X - 44.7; R2 = 0.99; P > 0.05 for 306 
control and HYPmild and Y = 1.7322X -76.126; R2 = 0.98; P > 0.05 for HYPmod. 307 
When leg blood flow measurements were not possible, LBF was calculated 308 
from the estimated leg V̇O2 (assuming that the increase in pulmonary V̇O2 from 309 
baseline reflected only the increase in leg V̇O2) (Mortensen et al., 2005, 2008; 310 
Calbet et al., 2007) and directly measured leg arterial-to-femoral venous O2 311 
difference.  312 
 313 
Statistics 314 
Differences between exercise conditions were assessed using a two-way 315 
repeated-measures ANOVA in which condition (Moderate heat stress, mild heat 316 
stress and control) and exercise phase (Rest, 20, 40, 60, 80 and 100%) were 317 
the main factors. Where a significant main effect was found, pairwise 318 
comparisons were made using the Holm-Bonferroni procedure. Statistical 319 
significance was set at P < 0.05 and all analyses were made using IBM SPSS 320 
Statistics (Version 20, IBM Corporation, Armonk, NY, USA). 321 
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  322 
Results 323 
Impact of heat stress and repeated incremental exercise on exercise 324 
capacity  325 
On the preliminary visit, heat stress exposure sufficient to induce HYPmod 326 
resulted in a reduction in Wmax by ~13 + 1%, despite a similar HRmax compared 327 
to control. To ensure a comparable percentage of Wmax across experimental 328 
conditions in the subsequent hyperthermia and control trials, the absolute work 329 
rates for the incremental stages in HYPmod were reduced by 13 + 1% (64 ± 2, 330 
128 ± 4, 193 ± 5, 257 ± 7 and 321 ± 9 W) compared to all other incremental 331 
tests (74 ± 2, 148 ± 4, 223 ± 7, 297 ± 9 and 371 ± 11 W; Fig. 1). 332 
 333 
During the control trial, where exercise capacity across the three incremental 334 
tests was the same, V̇O2max (4.4 + 0.1, 4.5 + 0.2 and 4.5 + 0.1 l min-1), HRmax 335 
(177 + 3, 181 + 3 and 182 + 3 beats min-1), TOes (38.2 + 0.1, 38.6 + 0.1 and 38.7 336 
+ 0.1 oC) and end-exercise MCA Vmean (68 + 5, 66 + 5 and 68 + 3 cm s-1) were 337 
not significantly different (Fig. 2). Moreover, the increase in V̇O2 per unit of 338 
power was linear from low to maximal exercise intensities in all 3 tests (9.2 ± 339 
0.3, 9.5 ± 0.3 and 9.1 ± 0.3 ml min-1 W-1; R2 = 0.99; P < 0.001). Given the 340 
similar exercise capacity, body temperatures and cardio-respiratory responses 341 
to exercise in the control trial, the following sections focus on the effects of 342 
temperature manipulation on whole-body haemodynamics in the hyperthermia 343 
trial only.  344 
      345 
Temperature and cardiorespiratory responses to heat stress 346 
Resting TB was elevated in HYPmod compared to HYPmild and control exercise 347 
conditions (37.5 ± 0.1 vs. 36.7 ± 0.1 and 37.0 ± 0.1 °C; P = 0.03), whereas Tsk 348 
was elevated in both heat stress conditions compared to control (~38.2 ± 0.3 vs. 349 
32.3 ± 0.4 °C; P < 0.001: Fig. 3A and B). During incremental exercise in 350 
HYPmod, TB was initially unchanged before increasing to a peak of 39.3 ± 0.1 °C 351 
(P < 0.01 vs. rest) whereas, in HYPmild and control, TB increased from rest to 352 
Wmax (39.1 ± 0.1 °C; P < 0.001) and was lower overall compare to HYPmod. Tsk 353 
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was maintained elevated in both heat stress conditions (~36.9 ± 0.4 vs. 32.0 ± 354 
0.4 °C; P < 0.001) and was maintained stable throughout exercise.  355 
 356 
Cardiorespiratory variables are presented in Table 1. Briefly, systolic and 357 
diastolic blood pressures were lower in HYPmod compared to HYPmild and control 358 
(P < 0.001). Respiratory frequency, CO2 production (V̇CO2) and minute 359 
ventilation (V̇E) increased with exercise intensity and were lower in HYPmod 360 
compared to HYPmild and control (both P < 0.001). End-tidal PO2 initially 361 
declined before increasing at Wmax, with the reverse response observed for 362 
PCO2; however, there were no differences between the exercise test conditions 363 
(P = 0.492).  364 
 365 
Brain, active limb and systemic haemodynamics  366 
At baseline, HR was 57 ± 3 beats min-1, two-legged blood flow 0.8 ± 0.1 l min-1, 367 
Q̇ 5.5 ± 0.4 l min-1 and MCA Vmean 64 + 1 cm s-1 (Fig. 4). At rest following 368 
passive heat stress or control, HR (88 ± 3 vs. ~76 ± 5 bpm), two-legged blood 369 
flow (1.9 ± 0.1 vs. ~1.0 ± 0.1 l min-1) and Q̇ (8.9 ± 0.7 vs. ~6.9 ± 0.8 l min-1) 370 
were elevated in HYPmod compared to HYPmild and control (all P < 0.05), 371 
whereas MCA Vmean was not different (~63 + 2 cm s-1). From rest to sub-372 
maximal exercise, HR and two-legged blood flow increased with exercise 373 
intensity in all conditions (P < 0.05 vs. rest) and MCA Vmean was elevated (Fig. 374 
4C; P < 0.05). However, overall, two-legged blood flow was lower (Fig. 4A; P < 375 
0.05) and HR higher, in HYPmod exercise compared to control exercise. At 376 
exhaustion, HR increased to similar peak values in HYPmod, HYPmild and control 377 
respectively (189 ± 4, 187 ± 3 and 184 ± 3 beats/min). In all conditions, the rate 378 
of rise in two-legged blood flow was attenuated, and MCA Vmean was reduced in 379 
all exercise conditions. Final two-legged blood flow (16.2 ± 1.3, 18.4 ± 1.1 and 380 
18.9 ± 1.1 l min-1) and MCA Vmean (57 + 1 vs. 66 + 3 cm s-1) were lower in lower 381 
in HYPmod than in HYPmild and control conditions. 382 
 383 
On the transition from rest to sub-maximal exercise, estimated Q̇ increased at a 384 
similar rate among conditions (~0.04 l min-1 W). Prior to exhaustion, Q̇ 385 
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paralleled the attenuation in two-legged blood flow, to a greater extent in 386 
HYPmod vs. HYPmild and control conditions (Gradient = 0.007 vs. 0.017 l min-1 387 
W), at a lower absolute work rate, and was similar at end-exercise (26.6 + 2 l 388 
min-1). 389 
   390 
Blood pressure, oxygen uptake and brain oxygenation  391 
At rest, MAP and FVP were not different among conditions (Fig. 4D). From rest 392 
to maximal exercise, MAP increased in all conditions, but was reduced in 393 
HYPmod compared to HYPmild and control, respectively (124 ± 7, 139 ± 7 and 153 394 
± 7 mmHg; P < 0.05). Femoral venous pressure increased with exercise 395 
intensity but was not different among exercise conditions.    396 
 397 
At rest, leg a-v O2diff was lower in HYPmod compared to HYPmild (24 ± 3 vs. ~56 ± 398 
7 ml l-1; P < 0.05: Fig. 4B), whereas resting systemic V̇O2 was not different 399 
among conditions (0.46 ± 0.03 l min-1; P = 0.47-0.84). During incremental 400 
exercise, leg a-vO2diff and systemic V̇O2 increased with intensity in all conditions 401 
(P < 0.05). At exhaustion, leg a-v O2diff was not different among conditions; 402 
however, systemic V̇O2max was reduced in HYPmod compared to HYPmild and 403 
control exercise conditions (3.94 ± 0.11 vs. 4.23 ± 0.13 and 4.23 ± 0.14 l min-1, 404 
respectively; P < 0.05). Compared to the 3 maximal incremental tests in the 405 
control trial, the rise in systemic V̇O2 per unit of power was identical from 20 to 406 
70-80%Wmax (9.6 + 0.3 ml min-1 W-1), but became attenuated thereafter (8.2 + 407 
0.6 ml min-1 W-1). At rest, NIRS derived rSO2% was elevated in HYPmod and 408 
HYPmild vs. control conditions (77 + 2 & 75 + 3 vs. 67 + 3%; P < 0.05) and 409 
remained unchanged across all conditions during incremental exercise, but 410 
declined before exhaustion (rSO2 ~64%; P < 0.05). 411 
 412 
Brain and active limb conductance, blood gases, plasma catecholamines 413 
and ATP  414 
Arterial and venous haemoglobin [Hb] and arterial oxygen content increased 415 
with incremental exercise in all conditions, despite a reduction in arterial oxygen 416 
saturation (all P < 0.05: Table 2 and 3). Arterial oxygen content was elevated in 417 
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both heat stress conditions and was higher in HYPmod compared to HYPmild and 418 
control up to 60% Wmax (P < 0.05).  Blood lactate increased exponentially and 419 
reached similar values at exhaustion in all experimental conditions (Table 3). 420 
However, arterial and venous glucose concentrations were elevated at exercise 421 
intensities ≥ 60% Wmax in the HYPmod compared to control and HYPmild.  422 
 423 
At rest, MCA vascular conductance was not different among conditions (Fig. 424 
5A). The elevations in limb and systemic perfusion in HYPmod were coupled to 425 
an enhanced limb vascular conductance (Fig. 5B; P < 0.05). MCA vascular 426 
conductance declined with exercise intensity. Contrastingly, limb vascular 427 
conductance increased with exercise intensity (P < 0.05), but was not different 428 
among conditions.     429 
 430 
At rest, arterial [NA] (Fig. 5C) was augmented in HYPmod vs. HYPmild and control 431 
conditions (3.7 + 0.8 vs. ~1.9 + 0.5 nmol l-1; P < 0.05), whereas venous [NA] 432 
was not different (data not shown). Thereafter, both arterial and venous [NA] 433 
increased with exercise intensity to a similar peak value (~48 + 5 nmol l-1). The 434 
rise in arterial [NA] was coupled to a blunted two-legged vascular conductance 435 
at maximal exercise intensities (R2 = 0.64; P < 0.01). At rest and during 436 
submaximal exercise, PaCO2 was maintained stable (Fig. 5D. However, beyond 437 
sub-maximal intensities, and in association with a marked increase in V̇E (Table 438 
1), PaCO2 declined to a similar end-exercise value across conditions (P < 0.05). 439 
The decline in PaCO2 was moderately related to the fall in MCA vascular 440 
conductance (R2 = 0.29; P < 0.01). Lastly, femoral venous (ATPfv) and arterial 441 
(ATPa) ATP concentrations were not different at rest, but increased up to sub-442 
maximal exercise intensities in all conditions (Fig. 5E and F). Beyond 80% 443 
Wmax, both ATPfv, in association with an attenuation in two-legged vascular 444 
conductance (R2 = 0.46; P < 0.01), and ATPa plateaued. 445 
 446 
Discussion 447 
To our knowledge this is the first study to separate the effects of skin 448 
hyperthermia from the combined effects of skin and internal hyperthermia on 449 
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brain and locomotor limb perfusion, aerobic metabolism and exercise capacity. 450 
The major novel finding was that marked skin hyperthermia was insufficient to 451 
compromise V̇O2max and incremental exercise capacity. A second novel finding 452 
was that superimposed internal and skin hyperthermia led to a faster decline, 453 
attenuation or plateau in brain and locomotor limb perfusion, which was 454 
mechanistically coupled to a plateau or decline in regional vascular 455 
conductance and a reduced arterial pressure. Finally, acceleration of the 456 
attenuation in brain and exercising limb flow appears to be an important 457 
mechanism by which combined skin and internal hyperthermia reduces aerobic 458 
metabolism and exercise capacity. Together, these findings demonstrate that 459 
the combination of skin and internal body hyperthermia is a critical factor in 460 
whether or not brain and active muscle perfusion and aerobic metabolism is 461 
compromised during incremental exercise to volitional exhaustion in hot 462 
environments.    463 
 464 
Skin hyperthermia does not independently compromise cardiovascular 465 
capacity or aerobic exercise performance 466 
In the present study we clamped skin temperature at a high level (i.e., ~37 oC 467 
vs. ~32 oC), without increasing internal temperature, prior to and during 468 
incremental exercise (HYPmild). To achieve this, the participants were first 469 
exposed to passive whole body heat stress for ~13 min and then combined 470 
whole body heat stress and exercise for an additional ~12.5 min. An important 471 
finding under these conditions was that V̇O2max and exercise capacity was the 472 
same compared to control exercise. Narrow core-to-skin temperature gradients, 473 
as seen in both HYP conditions in the present study (range; 0-2.6 oC), are 474 
purported to place a significant burden on cardiovascular capacity owing to the 475 
increased demand for skin blood flow (Rowell, 1986; Sawka et al., 2012). This 476 
theory has been taken to mean that high skin temperatures play a dominant role 477 
in reduced exercise capacity in the heat, by promoting the displacement of 478 
blood volume and flow to the skin thereby compromising active muscle 479 
perfusion (Tatterson et al., 2000; Ely et al., 2009; Kenefick et al., 2010; Lorenzo 480 
et al., 2010; Cheuvront et al., 2010; Sawka et al., 2012). However, we show that 481 
17 
 
brain, active limb and systemic blood flow during HYPmild is not reduced 482 
compared to that observed during control conditions. Moreover, the results on 483 
the experimental trial are supported by those on the control trial (Fig. 2) where, 484 
despite some differences in exercise internal temperature (~0.5 oC at 485 
exhaustion), exercise capacity was not different during repeated incremental 486 
exercise with normal skin temperature (~32 oC). Our findings collectively 487 
suggest that skin hyperthermia or small elevations in internal temperature alone 488 
do not compromise aerobic power or exercise capacity in trained individuals.   489 
 490 
In contrast, when combined internal and skin hyperthermia was present (i.e., 491 
achieved by extending the exposure to passive whole body heat stress to ~52 492 
min, while the exercise duration was not different), V̇O2max was reduced by 493 
~8%; a decline similar to that previously reported (Rowell et al., 1966; Klausen 494 
et al., 1967; Pirnay et al., 1970; Sawka et al., 1985; Nybo et al., 2001; 495 
Arngrímsson et al., 2004). The reduced aerobic power and work capacity were 496 
associated with a diminished arterial pressure, an early attenuation in active 497 
limb (and systemic perfusion), an advanced fall in brain blood flow and high 498 
internal and skin temperatures (39.3 and 37 oC, respectively) (Fig. 4). Restricted 499 
LBF, via a plateau in local vascular conductance, precedes fatigue during 500 
incremental (Mortensen et al., 2008) and constant load maximal exercise 501 
(González-Alonso & Calbet, 2003); whole body hyperthermia advances this 502 
cardiovascular instability and may explain the reduced maximal aerobic power 503 
(González-Alonso & Calbet, 2003). Our data demonstrate that the duration of 504 
heat exposure is critical to whether or not cardiovascular function is impaired 505 
during strenuous exercise in the heat stressed human.  506 
 507 
Impact of hyperthermia on blood flow and pressure at rest and during 508 
incremental exercise 509 
To understand the responses to regional hyperthermia during exercise and the 510 
potential underlying mechanisms, we need to first scrutinise the resting 511 
responses. At rest, combined internal and skin hyperthermia led to elevations in 512 
LBF and Q̇, accompanying a fall in limb a-vO2diff and a lower MAP, in close 513 
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agreement with the responses to passive heat stress (Barcroft et al., 1947; 514 
Rowell et al., 1969; Rowell, 1974; Minson et al., 1998; Crandall et al., 2008; 515 
Stöhr et al., 2011a; Pearson et al., 2011; Heinonen et al., 2011; Chiesa et al., 516 
2016). Interestingly, brief heat exposure, sufficient to raise Tsk to that 517 
experienced during combined internal and skin hyperthermia (HYPmild), but 518 
without elevations in Tc, led to a small increase in systemic (+ 1.3 l min-1) and 519 
limb blood flow (+ 0.25 l min-1) compared to baseline values. During passive 520 
whole body heat stress, interspersed by single leg exercise, elevations in 521 
whole-body perfusion (e.g. Q̇; 1.1 – 1.8 ± 0.3 l min-1, LBF; 0.5 ± 0.1 l min-1) and 522 
small but significant reductions in MAP have been observed with skin 523 
hyperthermia at rest without increases in Tc (Pearson et al., 2011; Stöhr et al., 524 
2011a). In a recent study from this laboratory, mild heat stress was also shown 525 
to induce small but significant increases in systemic and leg perfusion and HR 526 
(e.g. Q̇; 0.9 l min-1, LBF; 0.2 l min-1; 12 beats min-1), although these alterations 527 
occurred concomitant to small increases in Tc (~0.4oC) (Chiesa et al., 2016). It 528 
is therefore likely that any increased demand for skin and deep limb tissue 529 
blood flow, during passive mild hyperthermia, is met by blood flow redistribution 530 
from splanchnic vascular beds and a small increase in Q̇ and small reduction in 531 
MAP (Rowell et al., 1968; Crandall et al., 2008).  532 
 533 
A key question is whether passive hyperthermia-induced hyperperfusion and 534 
hypotension alters cardiovascular dynamics during incremental exercise. A 535 
novel finding in the present study was that the rise in LBF, limb a-vO2diff and the 536 
early increase in MCA Vmean from rest to sub-maximal exercise was similar 537 
among temperature manipulations. However, between 20-80% of Wmax, blood 538 
pressure and MCA Vmean were reduced with combined skin and internal 539 
hyperthermia compared to control exercise (Fig. 4), despite an estimated ~1.8 l 540 
min-1 elevation in Q̇. The present blood flow responses during sub-maximal 541 
exercise are consistent with a similar LBF and limb a-vO2diff but elevated Q̇ in 542 
trained individuals (Savard et al., 1988; Nielsen et al., 1993, 1997), but are in 543 
contrast to the classical observations of a suppressed Q̇ (from an exercise 544 
intensity equivalent to ~60% V̇O2max) in the study of Rowell et al. (1966). Prior to 545 
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exhaustion, brain perfusion was markedly reduced, whilst there was evidence of 546 
a plateau in two-legged (and systemic) blood flow. In all cases, combined 547 
internal and skin hyperthermia advanced this restriction in regional blood flow, 548 
despite a similar HRmax rate and limb O2 extraction. 549 
 550 
The attenuation in blood flow and vascular conductance at maximal exercise 551 
may involve the interaction of various reflex, chemical and thermal mechanisms, 552 
in different tissues of the body, responsible for regulating local vascular tone 553 
(Rowell, 1974; González-Alonso et al., 2004; González-Alonso, 2008; 554 
Mortensen et al., 2008; Mortensen & Saltin, 2014). To provide mechanistic 555 
insight into these circulatory alterations during incremental exercise, with 556 
differing combinations of body temperatures, we assessed a number of 557 
vasoactive substances implicated in the regulation of brain and muscle blood 558 
flow. Irrespective of the temperature manipulation, the fall (brain) or plateau in 559 
(two-legged) blood flow at maximal exercise intensities was coupled to a similar 560 
fall or plateau in regional vascular conductance (Fig. 5), indicative of 561 
vasoconstriction in the active brain and muscle vascular beds. Mechanistically, 562 
the brain blood flow velocity decline towards baseline values was associated 563 
with a hyperventilation-induced fall in PaCO2 (r = 0.54; P < 0.05); a potent 564 
vasoactive substance affecting cerebrovascular tone (Willie et al., 2012). These 565 
dynamics during graded exercise are supported by the literature (Hellstrom et 566 
al., 1996; Sato et al., 2011; Trangmar et al., 2014). On the other hand, the 567 
restriction in two-legged conductance, prior to exhaustion in all conditions, was 568 
related to a plateau in plasma ATP and an exponential rise in sympathetic 569 
vasoconstrictor activity even when leg vascular conductance and plasma ATP 570 
and [NA] were or tended to be higher in the hyperthermic trials (Fig. 5). It has 571 
previously been postulated that the influence of sympathetic vasoconstriction on 572 
vascular conductance can be “overridden” by metabolic vasodilation 573 
(Remensnyder et al., 1962; Rosenmeier et al., 2004). This theory can explain 574 
the regulation of muscle perfusion when exercising limb blood flow, and the 575 
intravascular vasodilator milieu including ATP, increase progressively during 576 
exercise against a background of relatively low sympathetic drive (González-577 
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Alonso et al., 2002; Rosenmeier et al., 2004; Mortensen et al., 2011). However, 578 
the present findings together with those during maximal and supra-maximal 579 
exercise (Mortensen et al., 2008), indicate that local vasoconstriction prevails 580 
during whole body, intense exercise in association with marked increases in 581 
sympathetic nerve activity (Saito et al., 1993; Ichinose et al., 2008) and a 582 
blunted rise in plasma ATP concentration. Thus, functional sympatholysis does 583 
not prevail at the maximal and supramaximal exercise domain with normal or 584 
elevated levels of local hyperthermia.  585 
 586 
Does cardiovascular strain contribute to hyperthermia-induced fatigue? 587 
An important question from the present study is which cardiovascular process 588 
underpins the reduced exercise capacity under physiologically stressful 589 
environments. Prevailing theory suggests that reduced aerobic capacity during 590 
exercise in the heat is due to reductions in active muscle blood flow, secondary 591 
to a substantial increase in skin perfusion, and despite active redistribution of 592 
blood flow from non-active tissues (Rowell, 1974, 1986). This theory was based 593 
on observations that body hyperthermia suppressed Q̇ during treadmill running, 594 
in un-trained and un-acclimatised individuals, compared to control conditions 595 
(Rowell et al., 1966); thus giving rise to the premise that the limited 596 
cardiovascular capacity is insufficient to meet the combined demands of heat 597 
dissipation (skin perfusion) and active muscle perfusion. Our findings 598 
demonstrate that the attenuated rise in systemic V̇O2 (from 9.6 to 8.2 ml min-1 599 
W-1) and reduced exercise capacity with combined internal and skin 600 
hyperthermia were coupled to an advanced fall in brain blood flow, and an early 601 
attenuation in LBF (that is, occurring at a lower absolute work rate); temporal 602 
responses that could feasibly result in a compromised local tissue aerobic 603 
metabolism when oxygen extraction reaches its upper limits (~ 90% in the 3 604 
conditions of this study) (González-Alonso & Calbet, 2003; Mortensen et al., 605 
2005, 2008; Calbet et al., 2007). In addition, our estimates of Q̇ suggest that 606 
systemic blood flow is similar at exhaustion among temperature manipulations; 607 
a conclusion supported by findings in trained participants, during constant-load 608 
cycling to volitional exhaustion, with combined internal and skin hyperthermia 609 
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(González-Alonso & Calbet, 2003). It is therefore unlikely that the absolute 610 
values of Q̇ and high skin blood flow explain early fatigue during incremental 611 
exercise.   612 
  613 
Reductions in cerebral O2 delivery (and oxygenation) might contribute to fatigue 614 
processes when hyperthermic (Nielsen & Nybo, 2003; Nybo & Secher, 2004; 615 
Todd et al., 2005; Rasmussen et al., 2010; Ross et al., 2012). However, it is 616 
unlikely that the moderate reductions in cerebral perfusion, seen here, and in 617 
previous studies (González-Alonso et al., 2004; Trangmar et al., 2014, 2015), 618 
can compromise cerebral metabolism to the extent that can explain the reduced 619 
aerobic power with a moderate hyperthermia. Rather, the advanced fall in 620 
cerebral perfusion, at lower absolute exercise intensities, is likely a 621 
consequence of the overall cardiovascular strain induced by strenuous exercise 622 
in the heat and the concomitant respiratory alkalosis. This is supported by 623 
similar findings in hypoxia where cerebral O2 delivery is markedly attenuated, 624 
despite elevated systemic blood flow and perfusion pressure (Subudhi et al., 625 
2009; Vogiatzis et al., 2011). Restoring reductions in cerebral O2 delivery, 626 
during exercise in hypoxia and with body hyperthermia, does not improve 627 
maximal aerobic power (Subudhi et al., 2011; Keiser et al., 2015), indicating 628 
that processes other than a suppressed cerebral O2 metabolism explain the 629 
early fatigue under physiological stressful environments.  630 
 631 
Our present findings highlight that combined skin and internal hyperthermia 632 
accelerates the attenuation in regional and systemic perfusion and reduces 633 
aerobic capacity during strenuous exercise. Blunted skeletal muscle and 634 
systemic blood flow and O2 delivery, with and without body hyperthermia, 635 
appear to be an important factor limiting aerobic capacity (González-Alonso & 636 
Calbet, 2003; Mortensen et al., 2005, 2008). We recognise that many 637 
interrelating factors likely contribute to the development of fatigue during 638 
exercise. In this context, exhaustion in the present experimental conditions may 639 
have resulted from the interaction of multiple inhibitory and excitatory regulatory 640 
processes in response to reduced O2 delivery, modified locomotor muscle and 641 
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brain metabolism, hyperthermia, altered central motor output, changed central 642 
nervous system neurotransmitter activity, and stimulation of muscle feedback 643 
mechanisms sensing local metabolic milieu (González-Alonso et al., 2008; 644 
Amann & Calbet, 2008; Meeusen & Roelands, 2010; Amann et al., 2011; 645 
Noakes, 2012; Sawka, 2012; Nybo et al., 2014; Morales-Alamo et al., 2015; 646 
Blain et al., 2016). Supporting the idea that the aetiology of fatigue during 647 
exercise is multifactorial and typified by cardiovascular strain and disturbed 648 
physiological homeostasis, we found that the single stressor skin hyperthermia 649 
was apparently met by compensatory physiological adjustments such that 650 
muscle and whole body aerobic energy provision was not compromised 651 
compared to control. The combination of multiple stressors triggered by whole 652 
body hyperthermia, however, resulted in a compromised aerobic capacity, 653 
associated with a blunted rise in active muscle and systemic perfusion.  654 
 655 
Methodological considerations 656 
Resting blood flow measurements were made using Doppler ultrasonography, 657 
rather than thermodilution, as less blood flow variability is seen with 658 
ultrasonography in resting conditions. We were unable to obtain direct 659 
measures of Q̇ during exercise; on this basis our conclusions based on 660 
estimated Q̇ are purposefully tempered. On the other hand, it is established that 661 
systemic O2 difference shares a strong linear relationship with leg O2 extraction 662 
during incremental exercise (Mortensen et al., 2008; Munch et al., 2014). 663 
Moreover, the adjustment to this relationship in HYPmod is in accordance with 664 
previous literature demonstrating a reduced systemic O2 extraction, per unit of 665 
leg O2 extraction with body hyperthermia (González-Alonso et al., 2004). 666 
Finally, our estimations on Q̇ dynamics during exercise were supported by 667 
those obtained with the Modelflow method. Nevertheless, future studies 668 
measuring central haemodynamics with different manipulations of internal and 669 
skin temperature are required to confirm the present observations. 670 
 671 
Conclusion 672 
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The present findings show that skin hyperthermia, in the absence of high 673 
internal temperatures, does not compromise cardiovascular capacity, maximal 674 
oxygen uptake or exercise performance during strenuous whole-body dynamic 675 
exercise. The fall in maximal aerobic power with combined internal and skin 676 
hyperthermia was associated with compromised active muscle metabolism due 677 
to reduced oxygen delivery. Taken together, these observations explain why 678 
aerobic exercise performance in hot environments is not universally impaired 679 
across all exercise modalities, as the deleterious effects of environmental heat 680 
stress are directly dependent upon heat exposure inducing whole-body 681 
hyperthermia and uncompensable physiological strain.  682 
 683 
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Table 1. Cardiorespiratory responses to incremental exercise with different grades of hyperthermia 
 
 
% of Wmax 
 
SBP 
(mmHg) 
 
DBP 
(mmHg) 
 
rf 
(breaths/min) 
 
V̇CO2 
(l min-1) 
 
V̇E 
(l min-1) 
 
PetO2 
(mmHg) 
 
PetCO2 
(mmHg) 
        
HYPmod 
 
       
Rest 138 ± 5† 73 ± 2 18 ± 1 464 ± 46 17 ± 2 111 ± 3 33 ± 2 
20 157 ± 7* 72 ± 3‡† 25 ± 2* 1353 ± 74* 39 ± 2* 103 ± 2* 38 ± 2* 
40 165 ± 10*‡† 73 ± 3‡† 29 ± 2* 1990 ± 81* 55 ± 2* 102 ± 1* 40 ± 1* 
60 179 ± 12* 74 ± 3† 32 ± 2* 2779 ± 72*‡ 77 ± 3*‡ 106 ± 1 40 ± 1* 
80 192 ± 11*‡† 79 ± 3‡† 41 ± 2* 3684±110*‡† 110 ± 5*‡† 111 ± 2 38 ± 1* 
100 211 ± 9*‡† 84 ± 3‡† 51 ± 3* 4422 ± 83*‡† 148 ± 7*‡† 115 ± 1* 34 ± 1 
        
HYPmild 
 
       
Rest 135 ± 5*† 72 ± 4† 16 ± 2 392 ± 19 14 ± 1 108 ± 2 34 ± 1 
20 162 ± 6*† 76 ± 4*† 25 ± 2* 1138 ±744* 39 ± 2* 100 ± 2* 39 ± 1* 
40 182 ± 8* 80 ± 3* 29 ± 2* 2124 ± 73* 58 ± 2* 102 ± 1* 40 ± 1* 
60 196 ± 12* 81 ± 5*† 34 ± 2* 3052 ± 92*† 86 ± 3*† 106 ± 1 40 ± 1* 
80 211 ± 11* 86 ± 5* 41 ± 2*† 4102 ± 103*† 126 ± 4*† 113 ± 1 36 ± 1* 
100 229 ± 11* 96 ± 6* 52 ± 3* 4733 ± 158* 161 ± 7* 116 ± 1* 34 ± 1 
        
Control 
 
       
Rest 155 ± 6‡ 83 ± 4 17 ± 2 404 ± 27 14 ± 1 108 ± 3 33 ± 1 
20 180 ± 4*‡  85 ± 3  26 ± 2* 1332 ± 75* 39 ± 2* 99 ± 1* 38 ± 1* 
40 200 ± 7* 87 ± 3 29 ± 2* 2058 ± 80* 57 ± 2* 102 ± 2* 40 ± 1* 
60 217 ± 7* 91 ± 3* 32 ± 2* 2878 ± 84* 79 ± 3* 104 ± 2 40 ± 1* 
80 227 ± 7* 92 ± 4* 39 ± 2* 3882 ± 114* 116 ± 6* 110 ± 2 38 ± 1* 
100 245 ± 8* 100 ± 5* 52 ± 3* 4729 ± 124* 165 ± 7* 117 ± 1* 33 ± 1 
        
Values are mean±SEM for 9 participants. Heart rates (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), respiratory 
frequency (rf), carbon dioxide production (V̇CO2), minute ventilation (V̇E), end-tidal oxygen (PetO2) and carbon dioxide tension (PetCO2). * 
different vs. rest P < 0.05, ‡ different vs. mild hyperthermia, † different vs. control. Presented symbols denote differences between 
conditions at the same relative percentage of Wmax. 
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Table 2. Blood gases and metabolite responses to incremental exercise with different grades of hyperthermia 
  
pH 
 
 
Hb 
(g l-1) 
SO2 
(%) 
PO2 
(mmHg) 
PCO2 
(mmHg) 
% of Wmax Arterial Venous Arterial Venous Arterial Venous Arterial Venous Arterial Venous 
           
HYPmod           
 
Rest 
 
7.46 ± 0.01‡† 
 
7.44 ± 0.01‡† 
 
148 ± 3‡† 
 
151 ± 3‡† 
 
97.5 ± 0.3 
 
85.1 ± 1.3‡† 
 
94.5 ± 2.9 
 
51.8 ± 1.3‡† 
 
38.2 ± 1.3 
 
42.1 ± 1.8 
20 7.47 ± 0.01‡† 7.39 ± 0.01*‡† 154 ± 3*‡† 157 ± 3*‡† 98.0 ± 0.2 36.3 ± 1.2* 100.3 ± 2.8 24.1 ± 0.6*‡† 36.2 ± 1.8* 53.7 ± 2.8* 
40 7.45 ± 0.01*‡† 7.35 ± 0.01* 154 ± 3*‡† 157 ± 3*‡† 97.8 ± 0.2 25.9 ± 2.0* 99.4 ± 3.1 21.1 ± 0.8* 37.0 ± 1.5‡ 60.3 ± 2.7* 
60 7.42 ± 0.01*† 7.31 ± 0.01* 155 ± 3*‡† 158 ± 3*‡† 97.5 ± 0.2* 21.0 ± 2.3* 99.3 ± 2.2 20.2 ± 1.1* 38.1 ± 1.2 65.9 ± 2.1* 
80 7.40 ± 0.01*‡† 7.26 ± 0.01*‡ 156 ± 3* 159 ± 4*‡† 97.2 ± 0.2* 16.8 ± 1.9*‡ 98.2 ± 2.9 18.9 ± 1.1* 36.2 ± 0.9 72.1 ± 1.9* 
100 7.36 ± 0.01*‡† 7.19 ± 0.01*‡ 157 ± 3* 161 ± 3*‡† 96.7 ± 0.2* 11.6 ± 1.3* 100.3 ± 2.4 17.8 ± 1.1* 33.7 ± 1.0* 78.1 ± 2.1* 
           
HYPmild           
 
Rest 
 
7.44 ± 0.01 
 
7.41 ± 0.01 
 
141 ± 2† 
 
143 ± 3 
 
97.9 ± 0.1 
 
71.5 ± 2.1 
 
95.7 ± 2.2 
 
38.2 ± 1.2 
 
38.2 ± 1.0 
 
44.3 ± 1.2 
20 7.44 ± 0.01 7.38 ± 0.01* 147 ± 3*† 149 ± 3*† 97.8 ± 0.1 32.4 ± 1.6* 95.1 ± 2.0 21.8 ± 0.5* 37.7 ± 1.1 52.5 ± 1.6* 
40 7.42 ± 0.01* 7.33 ± 0.01* 148 ± 3*† 150 ± 3*† 97.6 ± 0.2 23.4 ± 1.2* 95.9 ± 1.8 20.0 ± 0.5* 39.3 ± 0.9 61.4 ± 1.5* 
60 7.41 ± 0.00* 7.29 ± 0.00* 150 ± 3*† 153 ± 3*† 97.3 ± 0.1* 18.0 ± 1.2* 96.0 ± 1.7 18.6 ± 0.6* 38.6 ± 1.0 67.6 ± 1.2* 
80 7.38 ± 0.01* 7.23 ± 0.01*† 153 ± 3* 155 ± 3* 97.1 ± 0.2* 13.9 ± 1.4*† 97.3 ± 2.0 17.8 ± 1.0* 36.6 ± 1.2† 74.0 ± 1.5* 
100 7.32 ± 0.01*† 7.15 ± 0.01*† 156 ± 3*† 152 ± 3* 96.2 ± 0.3* 11.1 ± 1.2* 99.2 ± 2.5 17.9 ± 1.2* 33.3 ± 1.1* 79.0 ± 2.7* 
           
Control           
 
Rest 
 
7.44 ± 0.01 
 
7.41 ± 0.01 
 
138 ± 3 
 
140 ± 3 
 
97.9 ± 0.1 
 
66.6 ± 3.3 
 
95.8 ± 1.6 
 
36.4 ± 1.9 
 
37.4 ± 1.0 
 
43.9 ± 1.6 
20 7.44 ± 0.01 7.39 ± 0.01* 145 ± 3* 146 ± 3* 97.7 ± 0.2 32.3 ± 1.2* 93.5 ± 2.1 21.7 ± 0.3* 37.2 ± 1.0 50.2 ± 1.5* 
40 7.42 ± 0.00* 7.34 ± 0.01* 146 ± 3* 147 ± 3* 97.7 ± 0.2 23.0 ± 1.6* 97.5 ± 2.4 19.6 ± 0.6* 38.7 ± 1.0 59.5 ± 1.5* 
60 7.40 ± 0.00* 7.29 ± 0.00* 148 ± 3* 151 ± 3* 97.2 ± 0.2* 19.7 ± 1.6* 95.2 ± 1.8 19.2 ± 0.8* 39.4 ± 1.0* 66.0 ± 1.4* 
80 7.38 ± 0.01* 7.24 ± 0.01* 150 ± 3* 151 ± 3* 96.8 ± 0.2* 15.5 ± 1.5* 95.6 ± 2.5 18.6 ± 1.1* 38.3 ± 1.4 71.4 ± 1.6* 
100 7.33 ± 0.01* 7.17 ± 0.01* 153 ± 3* 153 ± 3* 96.3 ± 0.3* 12.0 ± 1.2* 98.8 ± 2.6 17.9 ± 1.1* 34.3 ± 1.3* 76.7 ± 2.2* 
           
Values are mean±SEM for 9 participants. pH, Haemoglobin (Hb), oxygen saturation (SO2%), partial pressures of oxygen (PO2) and carbon dioxide (PCO2) for arterial 
and femoral venous blood. * different vs. rest, ‡ different vs. mild hyperthermia, † different vs. control (all P < 0.05). Presented symbols denote differences between 
conditions at the same relative percentage of Wmax. 
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Table 3. Blood gases and metabolite responses to incremental exercise with different grades of hyperthermia 
 
 
 
 
 
CtO2 
(ml l-1) 
 
[Lac] 
(mmol l-1) 
[Glu] 
(mmol l-1) 
[HCO3-] 
(mmHg) 
ABE 
(mmol l-1) 
% of Wmax Arterial Venous Arterial Venous Arterial Venous Arterial Venous Arterial Venous 
           
HYPmod           
 
Rest 
 
199 ± 4‡† 
 
176 ± 3‡† 
 
1.0 ± 0.1 
 
1.1 ± 0.1 
 
5.8 ± 0.1 
 
5.8 ± 0.2 
 
27.3 ± 0.3‡† 
 
27.7 ± 0.3‡† 
 
3.0 ± 0.4‡† 
 
4.1 ± 0.5† 
20 209 ± 4*‡† 79 ± 2*‡† 1.7 ± 0.2* 2.1 ± 0.3* 5.9 ± 0.2 5.8 ± 0.3 26.6 ± 0.3*† 27.5 ± 0.4† 2.0 ± 0.5*† 6.5 ± 0.5*† 
40 208 ± 4*‡† 56 ± 4* 2.2 ± 0.3* 2.4 ± 0.4* 6.0 ± 0.2 6.0 ± 0.3 26.1 ± 0.5*† 27.0 ± 0.5* 1.5 ± 0.6* 6.8 ± 0.6*† 
60 209 ± 4*‡† 46 ± 5* 3.0 ± 0.4* 3.3 ± 0.5* 6.1 ± 0.2‡† 6.0 ± 0.3‡† 25.2 ± 0.5*† 26.0 ± 0.6*† 0.5 ± 0.7* 6.1 ± 0.8*† 
80 210 ± 4* 37 ± 4* 4.8 ± 0.5* 5.4 ± 0.5* 6.1 ± 0.3‡† 6.0 ± 0.3‡† 23.3 ± 0.5*‡† 23.8 ± 0.6*‡† -1.9 ± 0.7*‡ 4.2 ± 0.8‡† 
100 210 ± 4* 26 ± 3* 8.6 ± 0.6* 9.7 ± 0.5* 6.3 ± 0.3*‡† 6.3 ± 0.3*‡† 20.1 ± 0.6*‡† 20.3 ± 0.5*‡† -6.1 ± 0.8*‡† 0.4 ± 0.7* 
           
HYPmild           
 
Rest 
 
191 ± 3† 
 
140 ± 6 
 
1.3 ± 0.2 
 
1.5 ± 0.1 
 
5.9 ± 0.2 
 
5.7 ± 0.3 
 
26.0 ± 0.3† 
 
26.4 ± 0.3 
 
1.7 ± 0.4† 
 
3.4 ± 0.4 
20 198 ± 4*† 67 ± 4* 1.5 ± 0.2* 1.6 ± 0.2 5.9 ± 0.3 5.8 ± 0.3 26.0 ± 0.3 26.7 ± 0.3 1.6 ± 0.4 5.6 ± 0.4* 
40 199 ± 4*† 49 ± 2* 1.7 ± 0.2* 2.0 ± 0.3* 5.7 ± 0.3* 5.6 ± 0.3 25.7 ± 0.3* 26.3 ± 0.3 1.3 ± 0.4* 6.0 ± 0.5* 
60 202 ± 4*† 38 ± 3* 2.8 ± 0.3* 3.3 ± 0.4* 5.4 ± 0.2 5.3 ± 0.2 24.7 ± 0.3* 25.2 ± 0.4* -0.1 ± 0.5* 5.3 ± 0.5* 
80 205 ± 4* 30 ± 3* 5.7 ± 0.6* 6.3 ± 0.7* 5.3 ± 0.2* 5.2 ± 0.3 22.2 ± 0.5*† 22.5 ± 0.5* -3.1 ± 0.7*† 2.7 ± 0.7 
100 208 ± 4* 23 ± 2* 10.5 ± 0.8* 11.0 ± 0.8* 5.3 ± 0.3 5.2 ± 0.3 18.3 ± 0.5*† 18.8 ± 0.5* -8.3 ± 0.7*† -1.8 ± 0.8* 
           
Control           
 
Rest 
 
187 ± 4 
 
129 ± 9 
 
1.4 ± 0.2 
 
1.7 ± 0.2 
 
6.1 ± 0.2 
 
5.9 ± 0.1 
 
25.5 ± 0.2 
 
26.0 ± 0.3 
 
1.0 ± 0.3 
 
3.0 ± 0.5 
20 195 ± 4* 65 ± 3* 1.6 ± 0.2 1.7 ± 0.2 6.0 ± 0.1* 6.1 ± 0.1 25.5 ± 0.3 26.4 ± 0.3 1.0 ± 0.4 4.9 ± 0.5* 
40 197 ± 4* 47 ± 4* 1.7 ± 0.3 2.0 ± 0.3 5.9 ± 0.1 5.9 ± 0.2 25.4 ± 0.3 26.0 ± 0.4 0.9 ± 0.5 5.4 ± 0.6* 
60 198 ± 4* 41 ± 4* 2.6 ± 0.3* 3.2 ± 0.4* 5.6 ± 0.2* 5.5 ± 0.2* 24.5 ± 0.4* 24.9 ± 0.5* -0.1 ± 0.5* 4.8 ± 0.6* 
80 201 ± 4* 33 ± 3* 4.8 ± 0.5* 5.5 ± 0.6* 5.3 ± 0.2* 5.2 ± 0.3* 22.7 ± 0.5* 22.8 ± 0.6* -2.4± 0.8* 2.7 ± 0.8 
100 203 ± 4* 26 ± 3* 9.3 ± 0.6* 10.3 ± 0.9* 5.2 ± 0.3* 5.1 ± 0.3* 19.1 ± 0.5* 19.4 ± 0.6* -7.2± 0.8* -0.8 ± 0.8* 
           
Values are mean±SEM for 9 participants. Oxygen content (CtO2), Lactate concentration ([Lac]), Glucose concentration ([Glu]), sodium bicarbonate concentration 
([HCO3-])) and acid-base excess (ABE) for arterial and femoral venous blood. * different vs. rest P < 0.05, ‡ different vs. mild hyperthermia, † different vs. control. 
Presented symbols denote differences between conditions at the same relative percentage of Wmax. 
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Figure legends 
Figure 1. Sequence of the exercise protocols. Participants visited the 
laboratory on two occasions, with each trial consisting of 3 incremental cycling 
exercise tests at intensities relative to V̇O2ma. As HYPmod reduced V̇O2max 
(obtained on the preliminary trial), the absolute work rates of each stage were 
lower than all other incremental tests (321 + 9 W vs. 371 + 11 W). This 
adjustment allowed for comparisons between incremental tests, relative to 
V̇O2max, in either HYPmod or HYPmild/control, where the latter two conditions did 
not reduce V̇O2max. Passive heating/matched rest durations prior to exercise in 
HYPmod and HYPmild were 52 + 3 and 13 + 1 min respectively. A minimum of 1 h 
passive rest separated each incremental exercise bout.    
 
Figure 2. Brain and systemic haemodynamics, and systemic oxygen 
uptake in response to three incremental exercise bouts on the control 
trial. Values are means+SEM for 7 participants. Variables in figure 2B, C and D 
increased with exercise intensity (P < 0.01). 
 
Figure 3. Temperature responses to incremental exercise with different 
grades of hyperthermia. Femoral venous blood (A) and mean skin (B) 
temperatures are reported. Values are means±SEM for 9 participants. Moderate 
(internal and skin), mild (skin only) hyperthermia and control exercise are 
represented. * different vs. rest P < 0.05, ‡ different vs. mild hyperthermia, † 
different vs. control. Presented symbols denote differences between conditions 
at the same relative percentage of Wmax. 
 
Figure 4. Two-legged and brain haemodynamics, blood pressures and 
limb and systemic oxygen uptake in response to exercise with different 
grades of hyperthermia. Values are means±SEM for 9 participants. Variables 
in all figures (except Fig. 4C) increased with exercise intensity. Limb blood flow 
(Fig. 4A) increased with exercise intensity to ~80% Wmax (P < 0.05), but 
plateaued prior to exhaustion. ‡ different vs. mild hyperthermia, † different vs. 
 40 
 
control. Presented symbols denote differences between conditions at the same 
relative percentage of Wmax.    
 
Figure 5. Brain and two-legged vascular conductances, arterial [NA], 
PaCO2 and femoral venous and arterial plasma ATP in response to 
incremental exercise with different grades of hyperthermia. Values are 
means±SEM for 7 participants. ‡ different vs. mild hyperthermia, † different vs. 
control. Presented symbols denote differences between conditions at the same 
relative percentage of Wmax. 
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